Hudson Bay Capital Management LP Dbv Technologies S.A. Transaction History

Hudson Bay Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$5.75 - $21.85 $948,750 - $3.61 Million	-165,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.81 - $24.58 $672,400 - $983,199	40,000 Added 32.0%	165,000 $3.71 Million
Q2 2018 Aug 13, 2018	BUY	$18.6 - $24.94 $930,000 - $1.25 Million	50,000 Added 66.67%	125,000 $2.41 Million
Q1 2018 May 14, 2018	BUY	$20.86 - $26.6 $312,900 - $399,000	15,000 Added 25.0%	75,000 $1.73 Million
Q4 2017 Feb 12, 2018	BUY	$20.9 - $49.36 $1.04 Million - $2.47 Million	50,000 Added 500.0%	60,000 $1.48 Million
Q3 2017 Nov 13, 2017	BUY	$39.62 - $46.17 $396,200 - $461,700	10,000	10,000 $424,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $719M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hudson Bay Capital Management LP with notifications on news.